Altogen Biosystems Develops Powerful In Vivo RNAi Research Tool for Oncology
Summary
Optimized protocols included in the kit guide research methods and allow for maximum delivery, sustained mRNA knockdown, and reproducible results.Pharma companies actively investigating new RNAi-based therapeutics where cargo molecules such as a small proteins, DNA, siRNA, and microRNA are studied for their gene silencing potential to fight cancer.Altogen Biosystems has developed a Lipid-Based In Vivo Transfection Kit that is functionally tested in both rats and mice and providing powerful research tool in the field of RNAi application for oncology drug discovery.This produces a molecule with cationic properties and the interaction between the charged head and nucleic acids or any negatively charged cargo creates complex protected from nucleases in vivo.Lipid-based In Vivo Kit developed by Altogen Biosystems is a robust and effective tool for creating condensed transfection complexes.E-mail: techserv@altogen.com Contact Information Altogen Biosystems Alex Fanelli (702) 349-6103 altogen.com 848 Rainbow Blvd #823, Las Vegas, NV 89107.